J&J | JNJ - Pasivo Circulante

Precio De Mercado
227.50
Cambio Diario
-3.15 -1.37%
Mensual
-5.18%
Anual
47.17%
Q2 Expectativa
222.63




Pasivo Circulante Cambio Fecha
AbbVie USD 43.29B 3.9B 2025-12
Abbott USD 16.5B 1.91B 2025-12
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Baxter International USD 2.97B 805M 2025-12
Bayer EUR 32.58B 3.63B 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Biogen USD 3.35B 59.4M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
CONMED USD 315.04M 342K 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.81B 225.7M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Globus Medical USD 498.5M 32.54M 2025-12
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
Intuitive Surgical USD 2.51B 3.2M 2026-03
J&J USD 57.72B 3.59B 2026-03
Medtronic USD 9.5B 440M 2025-12
Merck USD 28.63B 2.59B 2025-09
Merit Medical Systems USD 239.76M 9.29M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
Stryker USD 7.79B 380M 2025-12
Tandem Diabetes Care USD 242.72M 9.82M 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12
Zoetis USD 2.24B 428M 2025-12